Most women notice steadier energy and fewer afternoon crashes within the first two weeks. Sugar cravings calm down between weeks three and six. The first real movement on the scale typically arrives between weeks seven and ten. Full metabolic recalibration takes consistent daily use over 90 days. Perimenopause metabolism took years to shift, so consistency matters more than speed.

No. This is the entire reason Saika exists. Berberine activates AMPK partially through antimicrobial action that disrupts your gut microbiome, which is why one in three women experience cramping, diarrhea, and bathroom emergencies on it. Cinnamaldehyde activates AMPK through direct cellular signaling, the same way Metformin does, without antimicrobial action on the gut. 92% of Saika customers who switched from Berberine report zero GI distress.

Saika is designed to work alongside your existing protocol. Many women stack it with HRT, low-dose Metformin, or hormone-balance supplements like Provitalize and Happy Mammoth. Saika uses DNA-verified Ceylon cinnamon, which is essentially coumarin-free and safer for long-term daily use than cassia. If you are on any prescription medication for blood sugar, diabetes, or insulin resistance, check with your doctor before starting, since cinnamaldehyde works on similar metabolic pathways.

Take one softgel daily with your first meal of the day. Cinnamaldehyde needs consistent daily exposure to gradually shift insulin sensitivity and metabolic function. There is no need to split doses or take it before meals like Berberine. One softgel. Once a day. With breakfast.

This is exactly the pattern Saika is designed for. Provitalize and Happy Mammoth work on gut microbiome and hormone metabolism, which do not address the AMPK pathway driving perimenopause weight gain. Berberine activates AMPK but through a mechanism that wrecks the gut of one in three women. Saika activates the same AMPK pathway through cinnamaldehyde, a structurally different mechanism that does not cause GI distress. It is the missing third option for women who have tried both ends of the supplement spectrum and gotten nothing for it.

A 12:1 extract means twelve pounds of raw Ceylon cinnamon are concentrated into one pound of extract, dramatically boosting the active cinnamaldehyde content. Combined with MCT oil suspension for absorption, this delivers a therapeutic dose of 7,200mg Ceylon cinnamon equivalent in a single softgel. Compared to grocery store cinnamon, the difference is not just potency but bioavailability. Most cinnamon supplements use unconcentrated powder, which delivers a fraction of the active compound.

Yes. Saika uses DNA-verified Ceylon cinnamon, which is essentially coumarin-free. Coumarin is the liver-toxic compound found in cassia (grocery store) cinnamon, which is why you cannot safely take grocery cinnamon every day. Saika is designed for daily long-term use, third-party tested every batch for coumarin content, and formulated for the woman who will be on a metabolic protocol for years, not weeks.

If you are gaining weight despite eating the same as before, crashing every afternoon, waking at 3am, and craving sugar at 9pm, you almost certainly have at least some degree of insulin sensitivity decline. Standard labs often miss it because they look at fasting glucose, not the actual cellular response to insulin. Cinnamaldehyde supports insulin sensitivity at the cellular level regardless of whether your labs have flagged it yet. Many women take Saika as a proactive metabolic foundation, not as a treatment for a diagnosed condition.

Cinnamaldehyde works on a different mechanism than GLP-1 agonists. Ozempic and similar drugs target the GLP-1 receptor, while cinnamaldehyde activates AMPK at the cellular level. They are not in conflict. However, since both can affect blood sugar, we recommend consulting your prescribing physician before stacking. Many women come to Saika after stopping Ozempic to maintain their results, or as a long-term natural foundation that supports metabolic health alongside whatever protocol they choose.